Related Experiment Videos
Retinoblastoma (Rb) gene product expression in lymphomas. Correlation with Ki67 growth fraction
J C Martínez1, M A Piris, M Sánchez-Beato
1Department of Pathology, Instituto Oftálmico (SRS-CAM), Toledo, Spain.
Abstract:
The retinoblastoma susceptibility gene (Rb) has been characterized as a tumour suppressor gene. Rb protein is involved in cell-cycle control, regulating gene transcription. The absence of Rb protein in inherited retinoblastoma has been proved to be the result of inactivation of both Rb alleles through mutation or deletion, according to the general model for suppressor genes. The frequent detection of Rb gene alterations in human tumours (retinoblastoma, osteosarcoma, bladder carcinoma, small-cell lung carcinoma) and the correlation with clinical outcome found in some tumours prompted us to study Rb gene expression in lymphoid tumours in an attempt to determine whether Rb gene expression is related to histological type and degree of aggressivity in human lymphomas. To establish normal levels of Rb protein, its expression was analysed in vitro on cytospin preparations from normal and pokeweed mitogen (PWM) or phytohaemagglutinin (PHA)-stimulated peripheral blood lymphocytes (PBLs), using a monoclonal antibody (PMG3-245). Rb protein expression in vivo was quantified using a computer analysis system (CAS) on frozen sections from reactive and neoplastic lymphoid tissue. As a control of tissue preservation, and to compare Rb expression and growth fraction, the tumours and cells were labelled simultaneously with the Ki67 monoclonal antibody. Normal and stimulated lymphocytes showed a gradual increase of Rb protein during progression of the cell cycle, with a peak in the M phase. G0-G1 cells had no detectable levels of Rb protein, suggesting that the Rb gene may act as a 'status quo' cellular growth fraction control mechanism. In reactive lymphoid tissue, Rb protein was mainly expressed in germinal centres (lymph nodes, tonsils) and cortical thymocytes.(ABSTRACT TRUNCATED AT 250 WORDS)
Insights
The retinoblastoma (Rb) gene, a tumor suppressor, regulates cell cycle control. Rb protein levels increase during the cell cycle, peaking in M phase, and are absent in G0-G1 cells, suggesting a role in controlling cell growth.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- The retinoblastoma (Rb) gene functions as a tumor suppressor, critical for cell-cycle control and gene transcription.
- Alterations in the Rb gene are frequently observed in various human tumors, including retinoblastoma and lung carcinoma.
- The role of Rb gene expression in lymphoid malignancies and its correlation with tumor characteristics require further investigation.
Purpose of the Study:
- To investigate Rb gene expression in human lymphomas.
- To determine if Rb gene expression correlates with histological type and aggressiveness of lymphomas.
- To elucidate the role of Rb protein in normal lymphocyte proliferation and lymphoid tissue.
Main Methods:
- In vitro analysis of Rb protein expression in normal and stimulated peripheral blood lymphocytes (PBLs) using monoclonal antibodies.
- In vivo quantification of Rb protein expression in reactive and neoplastic lymphoid tissue using computer analysis system (CAS).
- Simultaneous labeling with Ki67 antibody to assess tissue preservation and compare Rb expression with growth fraction.
Main Results:
- Normal and stimulated lymphocytes exhibited increasing Rb protein levels throughout the cell cycle, peaking in M phase.
- G0-G1 phase cells showed no detectable Rb protein, suggesting a role in maintaining cellular quiescence.
- In reactive lymphoid tissues, Rb protein was predominantly found in germinal centers and cortical thymocytes.
Conclusions:
- Rb protein expression is cell-cycle dependent, with low levels in quiescent cells, indicating a potential role as a growth fraction control mechanism.
- Rb gene expression patterns in lymphoid tumors may provide insights into their histological type and clinical behavior.
- Further research is warranted to fully understand the implications of Rb gene expression in lymphoma pathogenesis.